top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Characterization and Clinical Management of Dilated Cardiomyopathy
Characterization and Clinical Management of Dilated Cardiomyopathy
Autore Merlo Marco
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (232 p.)
Soggetto topico Medicine
Soggetto non controllato alternative splicing
arrhythmias
arrhythmic risk stratification
atrial fibrillation
biomarkers
calcium
cardiac channelopathy
cardiac magnetic resonance
cardiac magnetic resonance imaging
cardiac resynchronization therapy
cardiac sodium channel
cardiomyopathy
congenital heart disease
congestive heart failure
desmin
diastolic dysfunction
dilated cardiomyopathy
DNA methylation
duchenne muscular distrophy
epigenetics
gene therapy
genetics
heart
heart failure
laminopathy
late gadolinium enhancement
left atrial strain
left ventricle non-compaction cardiomyopathy
left ventricle sphericity index
left ventricular noncompaction
left ventricular reverse remodelling
LMNA
long axis strain
long-term outcomes
major adverse cardiovascular events
malignant ventricular arrhythmia
mammalian target of rapamycin (mTOR) complex-1
mdx
membrane stabilization
mitochondrial dysfunction
muscular dystrophy
myopathy
n/a
non-ischemic cardiomyopathy
non-sense mRNA decay
nonischemic dilated cardiomyopathy
NT-proBNP
oxidative stress
phospholamban
phosphorylation
precision medicine
RNA binding motif protein 20 (RBM20)
sarcomere
SCN5A
Serca2a
sex differences
supraventricular arrhythmia
systolic dysfunction
tachycardiomyopathy
titin
troponin T
ventricular arrhythmia
whole exome sequencing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557595503321
Merlo Marco  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Clinical Studies, Big Data, and Artificial Intelligence in Nephrology and Transplantation
Clinical Studies, Big Data, and Artificial Intelligence in Nephrology and Transplantation
Autore Cheungpasitporn Wisit
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (374 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato (cardiac) surgery
16S rRNA sequencing
acute kidney injury
acute rejection
allograft
allograft steatosis
anti-GBM disease
area under the precision-recall curve (AUCPR)
area under the receiver operating characteristic (AUROC)
artificial intelligence
artificial neural network (ANN), clinical natural language processing (clinical NLP)
big data
blood pressure
bone mineral density
butyrate-producing bacteria
C/D ratio
cardiovascular mortality
cellular crescent
chronic kidney disease
chronic kidney disease (CKD)
CKD-MBD
CKD-Mineral and Bone Disorder
clinical studies
collagen type VI
comorbidity
conservative management
conversion
cystatin C
death
deceased donor
dialysis
diarrhea
discharge summaries
dual-energy X-ray absorptiometry
elderly
electronic health record (EHR)
epidemiology
eradication
erythropoietin
estimated glomerular filtration rate (eGFR)
ethnic disparity
Eurotransplant Senior Program
everolimus
extracellular matrix
FGF-23
fibroblast growth factor 23
fibrosis
generalized linear model network (GLMnet)
genetic polymorphisms
global sclerosis
glomerulosclerosis
Goodpasture syndrome
Google TrendsTM
graft failure
graft survival
gut microbiome
gut microbiota
hemodialysis
hepatitis C infection
hospitalization
hyperfiltration
ICD-10 billing codes
immunosuppressed host
immunosuppression
immunosuppressive medication
in-hospital mortality
inflammation
inflammatory cytokines
intensive care
interferon-free regimen
kidney donor
kidney injury molecule (KIM)-1
kidney transplant
kidney transplant recipients
kidney transplantation
klotho
laboratory values
laparoscopic surgery
LCPT
lifestyle
lipopeliosis
live donors
liver transplantation
living donation
living kidney donation
living-donor kidney transplantation
long-term outcomes
machine learning
machine learning (ML)
MeltDose®
metabolism
metabolomics
minimally-invasive donor nephrectomy
nephrology
Nephrology
NLR
no known kidney disease (NKD)
organ donation
outcome
outcomes
patent ductus arteriosus
patient survival
phenotyping
PLR
pre-emptive transplantation
predictive value
procurement kidney biopsy
prolonged ischaemic time
Proteobacteria
public awareness
random forest (RF)
renal function
renal transplant recipient
renal transplantation
repeated kidney transplantation
risk prediction
risk stratification
robot-assisted surgery
RPGN
tacrolimus
tacrolimus metabolism
torquetenovirus
transplant numbers
transplantation
tubular damage
urine
vascular calcification
weekend effect
withdrawal
α-Klotho
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557367503321
Cheungpasitporn Wisit  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Biomarkers for Heart Disease
Novel Biomarkers for Heart Disease
Autore Lichtenauer Michael
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (420 p.)
Soggetto topico Medicine
Soggetto non controllato acute kidney injury
acute myocardial infarction
AMI
aneurysm
aortic disease
aortic regurgitation
atrial fibrillation
atrial myopathy
biomarker
biomarkers
carbohydrate antigen-125
cardiac biomarkers
cardiac intensive care units
cardiac magnetic resonance imaging
cardiometabolic disease
cardiometabolic risks
cardiovascular death
cardiovascular diseases
cardiovascular events
cardiovascular risk
cardiovascular surgery
catestatin
cell adhesion molecule
ceramides
ceruloplasmin
chronic heart failure
chronic kidney disease
circulating cells
circulating miRNAs
CKD
cohort studies
coronary artery disease
CVD
diet quality
echocardiography
ejection fraction
epicardial adipose tissue
epicardial fat
epicardial fat volume
FABP3
fatty acid-binding protein 3
Framingham risk score
GDF-15
GDF8
growth differentiation factor 15 (GDF-15)
H-FABP
healthy eating index
heart failure
heart failure decompensation
heart-type fatty acid-binding protein
heart-type fatty acid-binding protein (H-FABP)
herat failure
HF
HFpEF
HFrEF
hypertension
inflammatory marker
KLF4
left ventricular adverse remodelling
left ventricular ejection fraction
left ventricular systolic function
liver-type fatty-acid-binding protein
long-term outcomes
longitudinal strain
magnetic resonance imaging
magnetic resonance spectroscopy
metabolic syndrome
microRNA
miRNA
mitochondrial DNA (mtDNA)
mitochondrial dysfunction
muscle wasting
myocardial infarction
myocardial triglyceride content
myostatin
n/a
NAFLD
NAFLD fibrosis score
NT-proBNP
NYHA functional class
obesity
older women
operative risk
oxidative stress
PBMCS
Pentraxin-3
platelets
PPCI
pregnancy-associated plasma protein-A
primary prevention
reactive oxygen species (ROS)
renal dysfunction
repeated measurements
risk prediction
risk stratification
saliva
salivary biomarkers
sarcopenia
secondary prevention
SOCE
soluble suppression of tumorigenicity 2 (sST2)
soluble urokinase-type plasminogen activator receptor (suPAR)
sST2
STEMI
STIM1
sudden cardiac death
suPAR
synthetic phenotype
T1 mapping
TGF-β pathway
thyroid-stimulating hormone
troponin
vena contracta area
ventricular arrhythmia
ventricular tachycardia
very low-density lipoprotein
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557546203321
Lichtenauer Michael  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui